{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:13:21Z","timestamp":1770221601472,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T00:00:00Z","timestamp":1405641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s00467-014-2892-6","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T03:17:21Z","timestamp":1405567041000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children"],"prefix":"10.1007","volume":"30","author":[{"given":"Zhaoyang","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengqing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weizhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhong","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,18]]},"reference":[{"key":"2892_CR1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","volume":"27","author":"M Thun\u00f8","year":"2009","unstructured":"Thun\u00f8 M, Macho B, Eugen-Olsen J (2009) suPAR: the molecular crystal ball. Dis Markers 27:157\u2013172","journal-title":"Dis Markers"},{"key":"2892_CR2","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.2741\/3550","volume":"14","author":"S D\u2019Alessio","year":"2009","unstructured":"D\u2019Alessio S, Blasi F (2009) The urokinase receptor as an entertainer of signal transduction. Front Biosci 14:4575\u20134587","journal-title":"Front Biosci"},{"key":"2892_CR3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2821","volume":"11","author":"HW Smith","year":"2010","unstructured":"Smith HW, Marshall CJ (2010) Regulation of cell signalling by uPAR. Nat Rev Mol Cell Biol 11:23\u201336","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2892_CR4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.tcb.2007.06.006","volume":"17","author":"C Faul","year":"2007","unstructured":"Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P (2007) Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol 17:428\u2013437","journal-title":"Trends Cell Biol"},{"key":"2892_CR5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm1696","volume":"14","author":"C Wei","year":"2008","unstructured":"Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14:55\u201363","journal-title":"Nat Med"},{"key":"2892_CR6","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952\u2013960","journal-title":"Nat Med"},{"key":"2892_CR7","first-page":"103","volume":"2012","author":"T Kumagai","year":"2012","unstructured":"Kumagai T, Mouawad F, Takano T (2012) Pathogenesis of common glomerular diseases\u2014role of the podocyte cytoskeleton. Cell Health Cytoskelet 2012:103\u2013118","journal-title":"Cell Health Cytoskelet"},{"key":"2892_CR8","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/ndt\/gfr612","volume":"27","author":"B Zhang","year":"2012","unstructured":"Zhang B, Xie S, Shi W, Yang Y (2012) Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. Nephrol Dial Transplant 27:1746\u20131755","journal-title":"Nephrol Dial Transplant"},{"key":"2892_CR9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00109-012-0960-6","volume":"90","author":"B Zhang","year":"2012","unstructured":"Zhang B, Shi W, Ma J, Sloan A, Faul C, Wei C, Reiser J, Yang Y, Liu S, Wang W (2012) The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med 90:1407\u20131420","journal-title":"J Mol Med"},{"key":"2892_CR10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0961203313480398","volume":"22","author":"CC Cheng","year":"2013","unstructured":"Cheng CC, Lee YF, Lan JL, Wu MJ, Hsieh TY, Lin NN, Wang JM, Chiu YT (2013) Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model. Lupus 22:554\u2013561","journal-title":"Lupus"},{"key":"2892_CR11","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2215\/CJN.06170613","volume":"8","author":"S Sever","year":"2013","unstructured":"Sever S, Trachtman H, Wei C, Reiser J (2013) Is there clinical value in measuring suPAR levels in FSGS? Clin J Am Soc Nephrol 8:1273\u20131275","journal-title":"Clin J Am Soc Nephrol"},{"key":"2892_CR12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/TP.0b013e31829e6d40","volume":"96","author":"M Naesens","year":"2013","unstructured":"Naesens M, Meijers B, Sprangers B (2013) suPAR and FSGS: the gap between bench and bedside. Transplantation 96:368\u2013369","journal-title":"Transplantation"},{"key":"2892_CR13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcrc.2013.08.005","volume":"29","author":"K Donadello","year":"2013","unstructured":"Donadello K, Scolletta S, Taccone FS, Covajes C, Santonocito C, Cortes DO, Grazulyte D, Gottin L, Vincent JL (2013) Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients. J Crit Care 29:144\u2013149","journal-title":"J Crit Care"},{"key":"2892_CR14","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/clinchem\/43.10.1868","volume":"43","author":"RW Stephens","year":"1997","unstructured":"Stephens RW, Pedersen AN, Nielsen HJ, Hamers MJ, Hoyer-Hansen G, Ronne E, Dybkjaer E, Dano K, Brunner N (1997) ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem 43:1868\u20131876","journal-title":"Clin Chem"},{"key":"2892_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00126334-200404010-00002","volume":"35","author":"SR Ostrowski","year":"2004","unstructured":"Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H (2004) Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 35:337\u2013342","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2892_CR16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0141-9838.2004.00695.x","volume":"26","author":"M Perch","year":"2004","unstructured":"Perch M, Kofoed P, Fischer TK, Co F, Rombo L, Aaby P, Eugen-Olsen J (2004) Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 26:207\u2013211","journal-title":"Parasite Immunol"},{"key":"2892_CR17","first-page":"686","volume":"6","author":"J Eugen-Olsen","year":"2002","unstructured":"Eugen-Olsen J, Gustafson P, Sidenius N, Fischer TK, Parner J, Aaby P, Gomes VF, Lisse I (2002) The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 6:686\u2013692","journal-title":"Int J Tuberc Lung Dis"},{"key":"2892_CR18","first-page":"1","volume":"49","author":"R Katafuchi","year":"1998","unstructured":"Katafuchi R, Kiyoshi Y, Oh Y, Uesugi N, Ikeda K, Yanase T, Fujimi S (1998) Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 49:1\u20138","journal-title":"Clin Nephrol"},{"key":"2892_CR19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769\u2013776","journal-title":"J Am Soc Nephrol"},{"key":"2892_CR20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1440-1754.2007.01077.x","volume":"43","author":"W Wong","year":"2007","unstructured":"Wong W (2007) Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after 12-month follow-up: results of a 3-year national surveillance study. J Paediatr Child Health 43:337\u2013341","journal-title":"J Paediatr Child Health"},{"key":"2892_CR21","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s00467-009-1138-5","volume":"24","author":"D Mekahli","year":"2009","unstructured":"Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, van Damme-Lombaerts R, Palcoux J-B, Cachat F, Lavocat M-P, Bourdat-Michel G, Nobili F, Cochat P (2009) Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol 24:1525\u20131532","journal-title":"Pediatr Nephrol"},{"key":"2892_CR22","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","volume":"27","author":"W Wang","year":"2012","unstructured":"Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, Fu H, Du L, Liu A (2012) Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol 27:2073\u20132079","journal-title":"Pediatr Nephrol"},{"key":"2892_CR23","first-page":"825","volume":"49","author":"SH Yao","year":"2011","unstructured":"Yao SH, Mao JH, Xia YH, Wang DY, Chen YF, Fang CQ, Liu AM, Du LZ (2011) Clinical application of tacrolimus with low-dose prednisone in 21 children with steroid-resistant nephrotic syndrome. Chin J Pediatr 49:825\u2013828","journal-title":"Chin J Pediatr"},{"key":"2892_CR24","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1681\/ASN.2012030302","volume":"23","author":"C Wei","year":"2012","unstructured":"Wei C, Trachtman H, Li J, Dong C, Friedman AL, Gassman JJ, McMahan JL, Radeva M, Heil KM, Trautmann A, Anarat A, Emre S, Ghiggeri GM, Ozaltin F, Haffner D, Gipson DS, Kaskel F, Fischer DC, Schaefer F, Reiser J, PodoNet CFCS (2012) Circulating suPAR in two cohorts of primary FSGS. J Am Soc Nephrol 23:2051\u20132059","journal-title":"J Am Soc Nephrol"},{"key":"2892_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.ajkd.2012.10.011","volume":"61","author":"MJ Kemper","year":"2013","unstructured":"Kemper MJ, Wei C, Reiser J (2013) Transmission of glomerular permeability factor soluble urokinase plasminogen activator receptor (suPAR) from a mother to child. Am J Kidney Dis 61:9","journal-title":"Am J Kidney Dis"},{"key":"2892_CR26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ki.2013.55","volume":"84","author":"J Huang","year":"2013","unstructured":"Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Chen Y, Zhao MH (2013) Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis. Kidney Int 84:366\u2013372","journal-title":"Kidney Int"},{"key":"2892_CR27","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3182977ab1","volume":"96","author":"CR Franco Palacios","year":"2013","unstructured":"Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H (2013) Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates. Transplantation 96:394\u2013399","journal-title":"Transplantation"},{"key":"2892_CR28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ki.2013.505","volume":"85","author":"B Meijers","year":"2014","unstructured":"Meijers B, Maas RJH, Sprangers B, Claes K, Poesen R, Bammens B, Naesens M, Deegens JKJ, Dietrich R, Storr M, Wetzels JFM, Evenepoel P, Kuypers D (2014) The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis. Kidney Int 85:636\u2013640","journal-title":"Kidney Int"},{"key":"2892_CR29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2215\/CJN.07680712","volume":"8","author":"ME Bock","year":"2013","unstructured":"Bock ME, Price HE, Gallon L, Langman CB (2013) Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report. Clin J Am Soc Nephrol 8:1304\u20131311","journal-title":"Clin J Am Soc Nephrol"},{"key":"2892_CR30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, Dinda AK, Agarwal SK, Sopory S, Pandey RM, Hari P, Bagga A (2014) Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int 85:649\u2013658","journal-title":"Kidney Int"},{"key":"2892_CR31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","volume":"85","author":"T Wada","year":"2014","unstructured":"Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, Endo T, Muso E, Kamata K, Yokoyama H, Fujimoto K, Obata Y, Nishino T, Kato H, Uchida S, Sasatomi Y, Saito T, Matsuo S (2014) A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int 85:641\u2013648","journal-title":"Kidney Int"},{"key":"2892_CR32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00467-013-2452-5","volume":"28","author":"RJ Maas","year":"2013","unstructured":"Maas RJ, Deegens JK, Wetzels JF (2013) Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol 28:1041\u20131048","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2892-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-014-2892-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-014-2892-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T09:17:32Z","timestamp":1649668652000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-014-2892-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,18]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2892"],"URL":"https:\/\/doi.org\/10.1007\/s00467-014-2892-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,18]]}}}